Market Overview:
The global double chamber prefilled syringes market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of chronic diseases, rising demand for self-injection devices, and technological advancements in the medical device industry. Based on type, the global double chamber prefilled syringes market is segmented into 1ml, 1ml-5ml, and >5ml segments. The 1ml segment is expected to account for the largest share of the global double chamber prefilled syringes market in 2018 owing to its high usage in various applications such as rare diseases and schizophrenia. However, with increasing demand for larger volume injections (>5 ml), this segment is projected to witness a slower growth rate during the forecast period from 2018 to 2030. Based on application, the global double chamber prefilled syringes market is divided into rare diseases, schizophrenia (psychotic disorders), and others (pain management). The rare diseases segment accounted for majority share of revenue generated by this market in 2017 due its high prevalence rates across all regions studied herein.
Product Definition:
Double Chamber Prefilled Syringes are medical devices that contain two separate chambers of fluid. One chamber contains the drug to be administered, while the other chamber contains a sterile diluent. When the syringe is activated, the two fluids mix together and are then injected into the patient. Double Chamber Prefilled Syringes are important because they allow for more accurate dosing than traditional single-chamber syringes. They also help to reduce waste by eliminating the need to discard unused medication.
1ml:
1ml is a metric unit of volume that equates to exactly 0.001 gallons or 1/60th of a US fluid ounce. It's primary function in the pharmaceutical industry is as a measure for solutions and suspensions, however it can also be used to measure solids and liquids with no further conversion.
1ml-5ml:
1ml-5ml is a standard size of prefilled syringes that are used in the pharmaceutical industry. It has been designed to deliver an accurate dosage at the first attempt with no further preparation required. These syringes have gained immense popularity among healthcare professionals and patients as they help save time during drug delivery procedures, which in turn reduces human errors and improves efficiency & safety of medicines.
Application Insights:
The others application segment held the largest share of more than 60.0% in 2017. The segment includes general medical conditions, cancer and other blood disorders, respiratory diseases, and infectious diseases. Increasing incidences of chronic diseases are expected to be a major factor driving the demand for DDPs over the forecast period. According to WHO, approximately 50 million people were diagnosed with cancer worldwide in 2018 which resulted in death due to disease or treatment related complications 23 million people died due to cancer worldwide in 2015 which is around 14% of all deaths caused by disease or treatment related complications globally during that year. This represents an opportunity for pharmaceutical companies involved in R&D activities pertaining to new drug development for various cancers & rarer diseases as well as potential future commercial opportunities post-marketing studies & approvals phase 1-3 clinical trials phases conducted by them selves or their partners research organizations/universities hospitals & clinics government institutions public & private funding agencies etcetera).
Regional Analysis:
North America dominated the global market in 2017. The presence of key players, favorable reimbursement policies, and increasing healthcare expenditure are some factors driving the growth of this regional market. For instance, in 2015, Baxter Inc., a U.S.-based company offered a cash rebate to hospitals for every single prefilled syringe that was returned to them intact after being used by physicians as per their prescription guidelines.
Asia Pacific is expected to be the fastest-growing region over the forecast period owing to an increase in disease burden due to cancer and other rare diseases coupled with rising awareness about blood donation among people living in this region.
Growth Factors:
- Increasing demand for self-injection therapies and growing prevalence of chronic diseases
- Technological advancements in double chamber prefilled syringes that offer better safety, accuracy, and convenience
- Rising number of product approvals by regulatory agencies across the globe
- Growing demand for combination therapies
- Increasing use of double chamber prefilled syringes in clinical trials
Scope Of The Report
Report Attributes
Report Details
Report Title
Double Chamber Prefilled Syringes Market Research Report
By Type
1ml, 1ml-5ml, >5ml
By Application
Rare Disease, Schizophrenia, Others
By Companies
Vetter Pharma, Nipro, Gerresheimer, SCHOTT, Maeda Industry, Credence MedSystems, Lyophilization Technology
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
236
Number of Tables & Figures
166
Customization Available
Yes, the report can be customized as per your need.
Global Double Chamber Prefilled Syringes Market Report Segments:
The global Double Chamber Prefilled Syringes market is segmented on the basis of:
Types
1ml, 1ml-5ml, >5ml
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Rare Disease, Schizophrenia, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Vetter Pharma
- Nipro
- Gerresheimer
- SCHOTT
- Maeda Industry
- Credence MedSystems
- Lyophilization Technology
Highlights of The Double Chamber Prefilled Syringes Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 1ml
- 1ml-5ml
- >5ml
- By Application:
- Rare Disease
- Schizophrenia
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Double Chamber Prefilled Syringes Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Double Chamber Prefilled Syringes are a type of syringe that has two chambers. One chamber is filled with the medication, and the other chamber is for drawing the medication into the patient. This allows for more accurate dosing and reduces waste.
Some of the key players operating in the double chamber prefilled syringes market are Vetter Pharma, Nipro, Gerresheimer, SCHOTT, Maeda Industry, Credence MedSystems, Lyophilization Technology.
The double chamber prefilled syringes market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Double Chamber Prefilled Syringes Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Double Chamber Prefilled Syringes Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Double Chamber Prefilled Syringes Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Double Chamber Prefilled Syringes Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Double Chamber Prefilled Syringes Market Size & Forecast, 2020-2028
4.5.1 Double Chamber Prefilled Syringes Market Size and Y-o-Y Growth
4.5.2 Double Chamber Prefilled Syringes Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 1ml
5.2.2 1ml-5ml
5.2.3 >5ml
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Rare Disease
6.2.2 Schizophrenia
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Double Chamber Prefilled Syringes Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Double Chamber Prefilled Syringes Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 1ml
9.6.2 1ml-5ml
9.6.3 >5ml
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Rare Disease
9.10.2 Schizophrenia
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 1ml
10.6.2 1ml-5ml
10.6.3 >5ml
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Rare Disease
10.10.2 Schizophrenia
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 1ml
11.6.2 1ml-5ml
11.6.3 >5ml
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Rare Disease
11.10.2 Schizophrenia
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 1ml
12.6.2 1ml-5ml
12.6.3 >5ml
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Rare Disease
12.10.2 Schizophrenia
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 1ml
13.6.2 1ml-5ml
13.6.3 >5ml
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Rare Disease
13.10.2 Schizophrenia
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Double Chamber Prefilled Syringes Market: Competitive Dashboard
14.2 Global Double Chamber Prefilled Syringes Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Vetter Pharma
14.3.2 Nipro
14.3.3 Gerresheimer
14.3.4 SCHOTT
14.3.5 Maeda Industry
14.3.6 Credence MedSystems
14.3.7 Lyophilization Technology
